US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Newron Pharmaceuticals Spa. (NP5) 銘柄情報

Newron Pharmaceuticals Spa. (NP5)

12.95

-0.30

(-2.26%)

終了 6月10日 5:00AM

Newron Pharmaceuticals Spa. (NP5) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

12.95

( -2.26% )

買値

12.90

売値

13.00

出来高

1,938

12.85 日の範囲 13.20

7.05 52 週間の範囲 34.15

時価総額

前日終値

13.25

始値

13.20

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

81,847 €

発行済株式数

20,014,585

配当利回り

PER

-20.05

1 株当たり利益 (EPS)

-0.66

歳入

19.13M

純利益

-13.24M

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European... Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company’s lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.newron.com

本社

Bresso, Italy

設立

1999

Newron Pharmaceuticals Spa. is listed in the Healthcare sector of the Tradegate (DE) with ticker NP5. The last closing price for Newron Pharmaceuticals was 13.25 €. Over the last year, Newron Pharmaceuticals shares have traded in a share price range of 7.05 € to 34.15 €.

Newron Pharmaceuticals currently has 20,014,585 shares in issue. The market capitalisation of Newron Pharmaceuticals is 259.19 € million. Newron Pharmaceuticals has a price to earnings ratio (PE ratio) of -20.05.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.1	-7.82918149466	14.05	14.2	12.8	7045	13.36593283	DE
4	-2.6	-16.7202572347	15.55	16.75	12.8	4801	14.55672103	DE
12	-4.47	-25.6601607348	17.42	19	12.75	5202	15.72058842	DE
26	-7.65	-37.1359223301	20.6	34.15	12.75	6861	21.34744266	DE
52	4.45	52.3529411765	8.5	34.15	7.05	6053	17.46378837	DE
156	8.53	192.986425339	4.42	34.15	4.2	7352	10.87327238	DE
260	10.6	451.063829787	2.35	34.15	1.13	5645	9.66952099	DE

NP5 - Frequently Asked Questions (FAQ)

What is the current Newron Pharmaceuticals Spa. share price?

The current share price of Newron Pharmaceuticals Spa. is 12.95 €

How many Newron Pharmaceuticals Spa. shares are in issue?

Newron Pharmaceuticals Spa. has 20,014,585 shares in issue

What is the market cap of Newron Pharmaceuticals Spa.?

The market capitalisation of Newron Pharmaceuticals Spa. is EUR 259.19M

What is the 1 year trading range for Newron Pharmaceuticals Spa. share price?

Newron Pharmaceuticals Spa. has traded in the range of 7.05 € to 34.15 € during the past year

What is the PE ratio of Newron Pharmaceuticals Spa.?

The price to earnings ratio of Newron Pharmaceuticals Spa. is -20.05

What is the cash to sales ratio of Newron Pharmaceuticals Spa.?

The cash to sales ratio of Newron Pharmaceuticals Spa. is 14.46

What is the registered address of Newron Pharmaceuticals Spa.?

The registered address for Newron Pharmaceuticals Spa. is Via Antonio Meucci 3, Bresso, Milan, 20091

What is the Newron Pharmaceuticals Spa. website address?

The website address for Newron Pharmaceuticals Spa. is www.newron.com

Which industry sector does Newron Pharmaceuticals Spa. operate in?

Newron Pharmaceuticals Spa. operates in the Biotechnology & Life Sciences sector

Lazerator

Lazerator 59秒前

So with LWLG's patents, I wonder how NLM's polymer gets around them? Surely there are ways to accomplish the same thing with different materials. Gorrila glass has a particular formulation I assume. You might get the same properties with a different formulation that's not covered by their patent.

chen1992

chen1992 3分前

MarcoPolo4

MarcoPolo4 3分前

You are entitled to your opinion on the stock and its value but your opinion is based on many assumptions which are not based on facts,
There are no electro-optic polymers that are operating in the commercial market today. LWLG is in advanced work with several Fortune 500 companies to incorpo

Preciouslife1

Preciouslife1 4分前

https://finance.yahoo.com/markets/crypto/articles/xrp-hits-most-critical-level-205555222.html

Lazerator

Lazerator 5分前

Actually I'm here trying to understand the value. With a company stated addressable market of $2-4B for EO modulators, and with LWLG's market cap recently at $2B I wonder how good of a value it is. Sure it can trade at a higher market cap but how much?

nowwhat2

nowwhat2 6分前

https://investorshub.advfn.com/uimage/uploads/2026/6/9/prhosxrp_june_9_6m_supp_sig.jpg

I mean, it's not like we're talkin' rocket science, right ?

.

1manband

1manband 6分前

When the entries come out for that day's races, it will show the owner of each horse. He raced under his own name (rather than as a stable or other organization, such as an LLC), so it was always easy to find his entries. If he passed, the entries should reflect that as the horse's ownership will no

Pennyseeker

Pennyseeker 6分前

JFC, this press release is so full of bullsh*t lies and regurgitated falsehoods it’s amazing they have the nerve to publish this,… or maybe it’s plain old stupidity than nerve.
Lawson should be in jail. Total grifter

marzan

The market is finally waking up to the pressure building around Apple’s AI/Siri issues in China and Europe. Apple itself acknowledged regulatory/legal hurdles tied to rolling out these features globally. That narrative is no longer “conspiracy” — it is now mainstream discussion.

Europ

MannSinger

MannSinger 9分前

With 5% interest, it's $1B; with 10% interest, it's $1.5B

If Gov is getting 10% dividend or interest, investor should also get 10% coumpond interest.

This scam will be over soon.

Truth and Transparency

Truth and Transparency 11分前

FACTS: This is the current return on NB investment. Mark Smith NEVER FAILS TO DISAPPOINT!!!! Get rid of those MF parasites from GXII off the BOD and get some credibility back Mark!

6-month
-24.74%
Year to date (YTD)
-5.85%
5-year
-54.51%
10-ye

Dabeav

Dabeav 12分前

Hopefully it will bounce off of it, it usually does, but Trump kicking the can down the road w F2 and with Iran.

Yooperman

Yooperman 12分前

I thought you weren't an investor in this company anymore.

marzan

marzan 13分前

Europe and China together account for roughly 40%+ of Apple’s yearly revenue, corresponding to roughly $160B–$200B annually. Even a modest slowdown in iPhone upgrade cycles due to delayed AI/Siri rollout could translate into tens of billions in lost revenue opportunity over time. And if competitors

IH Geek [Dave]

IH Geek [Dave] 14分前

Nah. You wind up here when you open multiple accounts in violation of the terms of service. More than once.

gdl

No let up for this CORRECTION. CPI, Oil Inventories. OUCH!
I just need a steady recovery from any drops early. That tells me it is on pure hope and a prayer we stay the course with record breaking earnings and market highs by end of year. This is just a small diversion that will rectify itse

Maxinvestor89

Maxinvestor89 18分前

I think they are waiting for SEII to become OTCID before releasing a PR

They got partial access to OTCIQ (I believe it was last week or the week before, when the profile started to get partially updated on OTCM)

It usually takes a couple more days to get full access and

bananarama

bananarama 18分前

AMEN, SILK! Our days of success are imminent. All it takes is patience. GO KBLB!

sonofgodzilla

sonofgodzilla 18分前

$BBUZ - Nice Retail Support Today: Close .0199 + 9.34% 254,000 Shares Traded, ALL BUYS!
GLTA!
SOG

Kool Aid Man

Kool Aid Man 19分前

EMUS "owns" the silver mine until it's PAID-IN-FULL

So far HIRU paid a $30k down payment followed by a $50k fee/fine to renegotiate the payment schedule because the Royal Shecky with the bottomless pit of cash couldn't/ wouldn't pay the $1.1 million installment by the due date. There'

Grouse Hunter

Grouse Hunter 19分前

Yep. Things that make you hmmm.

spartex

spartex 20分前

In response to KCC's post, you are saying Broadcom is signaling lower modulator/PIC margins for Lightwave's deals? at least show your homework as otherwise, your comment is kinda strange, to put it lightly.

learningcurve2020

learningcurve2020 24分前

You’re wrong on just about all your comments on voting fraud and you’ll soon find out why.

Vitamin310

Vitamin310 24分前

Newron Pharmaceuticals

Discovery Silver

WisdomTree STOXX Europe ...

Direxion Daily S&P Biote...

Macondray Capital Aquisi...

Salarius Pharmaceuticals

Graniteshares 3x Long Te...

JPMorgan American Invest...

Western Asset Total Retu...

Harley-Davidson

Agf Total Return Bond Fu...

Aethlon Medical

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。